Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. (Q40473787)

20 September 2017

title

Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. (English)

1 reference

Rift Valley fever phlebovirus

20 September 2017

main subject

0 references

vaccine

0 references

author name string

Wallace DB

1

1 reference

20 September 2017

Ellis CE

2

1 reference

20 September 2017

Espach A

3

1 reference

20 September 2017

Smith SJ

4

1 reference

20 September 2017

Greyling RR

5

1 reference

20 September 2017

Viljoen GJ

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

5 July 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

24

1 reference

20 September 2017

issue

49-50

1 reference

20 September 2017

page(s)

7181-7189

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

20 September 2017

1 reference

An epizootic of Rift Valley fever in Egypt in 1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Genetic Analysis of Viruses Associated with Emergence of Rift Valley Fever in Saudi Arabia and Yemen, 2000-01

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Immune responses to recombinants of the South African vaccine strain of lumpy skin disease virus generated by using thymidine kinase gene insertion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Observations on the epidemiology of lumpy skin disease in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

A single vaccine for the control of capripox infection in sheep and goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

The characterization of African strains of capripoxvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Trial of a capripoxvirus-rinderpest recombinant vaccine in African cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Relationships of capripox viruses found in Kenya with two Middle Eastern strains and some orthopox viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

One-step procedure for screening recombinant plasmids by size.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

The pMTL nic- cloning vectors. I. Improved pUC polylinker regions to facilitate the use of sonicated DNA for nucleotide sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Evidence of sheep pox in Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Clinical and antigenic relationship between isolates of sheep and goat pox viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.06.041

1 reference

20 September 2017

1 reference